Optimization of CRT Using an ECG Vest

Completed · Not applicable

Conditions studied: Heart Failure

In brief

Despite advancements in implant technology and various techniques of optimization, there is still around 30% non-responder rate to cardiac resynchronization therapy (CRT). This study will assess the potential benefit of a body surface mapping technology to optimize CRT devices in the chronic sub-optimal responder setting.

Key facts

Study ID

NCT02699944

Run by

Alan J. Bank, MD

People needed

56

Starts

2015-11-01

Expected to finish

2021-08-17

Last updated by the study team

2021-09-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients (or their legal guardian) must be willing to provide Informed Consent and a data privacy (HIPPA) authorization
• Patient is or will be followed clinically in the UHVC CRT Optimization Clinic
• Patient has been implanted with a CRT device for at least 6 months
• Patient received an echocardiogram prior to CRT implant
• Patients must be ≥ 18 years of age

You may not qualify if…

• Patient's EF is currently ≥ 50%
• Patients who are pregnant
• Patient has unhealed / open wounds on the torso and/or has a history of severe allergic reactions from ECG gel / electrode glue

Where it is running

• United Heart & Vascular Clinic — Saint Paul, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.